A merger between the vitamin operations of both German chemical group BASF and Japan-based Takeda Chemical Industries Ltd has been approved by the British antitrust authorities. BASF has announced the implementation of a capital expenditures program worth €600m (US$507m) in a bid to ensure that the merged company leads the vitamin sector.